Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101701004 Publication Model: Print Cited Medium: Internet ISSN: 2472-1727 (Electronic) NLM ISO Abbreviation: Birth Defects Res Subsets: MEDLINE
    • Publication Information:
      Original Publication: Hoboken, N.J. : John Wiley & Sons, Inc.
    • Subject Terms:
    • Abstract:
      Substance use (e.g., alcohol, marijuana, opioids, cocaine., etc,) use often initiates during adolescence, a critical period of physiological and social development marked by an increase in risk-taking due, in part, to heightened motivation to obtain arousal from rewards. Substance use during adolescence has been associated with a greater risk of substance use disorders (SUD) in adulthood. Although use rates for most substances have remained relatively stable, the frequency of marijuana use and the perception that regular marijuana use is not harmful has increased in adolescents. Furthermore, the nonmedical use of opioids has increased, particularly in the South, Midwest, and rural low-income communities. Substance use in adolescence has been associated with adverse structural and functional brain changes and, may exacerbate the natural "imbalance" between frontal/regulatory and cortical-subcortical circuits, leading to further heightened impulsive and reward-driven behaviors. Exercise increases growth and brain-derived neurotrophic factors that stimulate endogenous dopaminergic systems that, in turn, enhance general plasticity, learning, and memory. Exercise may help to reinforce the "naïve" or underdeveloped connections between neurological reward and regulatory processes in adolescence from the "bottom up" and "offset" reward seeking from substances, while concomitantly improving cardiovascular health, as well as academic and social achievement. In this review, we provide an overview of the current state of substance use in adolescents and rationale for the utilization of exercise, particularly "assisted" exercise, which we have shown increases neural activity in cortical-subcortical regions and may modulate brain dopamine levels during adolescence, a unique window of heightened reward sensitivity and neural plasticity, for the prevention and adjunctive treatment of SUD.
      (© 2017 Wiley Periodicals, Inc.)
    • References:
      West J Nurs Res. 2016 Sep;38(9):1155-84. (PMID: 27226208)
      J Subst Abuse Treat. 2015 May;52:1-9. (PMID: 25641736)
      Am J Psychiatry. 2015 Jun;172(6):531-42. (PMID: 25982660)
      Arch Pediatr Adolesc Med. 1999 Mar;153(3):286-91. (PMID: 10086407)
      Biol Psychiatry. 2016 Apr 1;79(7):e17-31. (PMID: 26858212)
      Neuroimage. 2010 Feb 1;49(3):2536-43. (PMID: 19913102)
      J Adolesc Health. 2012 Jul;51(1):6-17. (PMID: 22727071)
      J Neurosci. 2005 Sep 21;25(38):8680-5. (PMID: 16177036)
      Drug Alcohol Depend. 2015 Apr 1;149:40-8. (PMID: 25682478)
      Eur J Public Health. 2006 Apr;16(2):179-84. (PMID: 16126743)
      Curr Psychiatry Rep. 2017 Jan;19(1):5. (PMID: 28120255)
      Dev Cogn Neurosci. 2015 Dec;16:110-120. (PMID: 26190276)
      ScientificWorldJournal. 2012;2012:901741. (PMID: 22629222)
      Clin EEG Neurosci. 2009 Jan;40(1):31-8. (PMID: 19278130)
      Am J Drug Alcohol Abuse. 2015 Jan;41(1):7-15. (PMID: 25397661)
      Psychosom Med. 2016 Apr;78(3):354-64. (PMID: 26513517)
      Behav Brain Funct. 2010 Apr 23;6:24. (PMID: 20416052)
      Neurotoxicol Teratol. 2016 Sep - Oct;57:20-29. (PMID: 27687470)
      Neurotoxicol Teratol. 2002 May-Jun;24(3):309-20. (PMID: 12009486)
      Front Behav Neurosci. 2015 Jul 28;9:196. (PMID: 26283937)
      Exerc Sport Sci Rev. 2011 Jul;39(3):140-9. (PMID: 21508844)
      Dev Cogn Neurosci. 2015 Dec;16:101-109. (PMID: 25953106)
      J Stud Alcohol Drugs. 2012 Sep;73(5):749-60. (PMID: 22846239)
      Brain Cogn. 2010 Feb;72(1):124-33. (PMID: 19695759)
      Rehabil Psychol. 2016 Nov;61(4):380-388. (PMID: 27831730)
      Front Psychiatry. 2013 Nov 06;4:138. (PMID: 24223560)
      Curr Pharm Des. 2014;20(25):4112-8. (PMID: 24001294)
      Mov Disord. 2010;25 Suppl 1:S141-5. (PMID: 20187247)
      Neurosci Biobehav Rev. 2016 Jul;66:15-32. (PMID: 27118134)
      Dev Neurosci. 2010 Aug;32(3):249-56. (PMID: 20693803)
      Drug Alcohol Rev. 2017 May;36(3):337-351. (PMID: 28334456)
      Drug Alcohol Depend. 1995 Nov;40(1):9-15. (PMID: 8746919)
      Trends Neurosci. 2002 Jun;25(6):295-301. (PMID: 12086747)
      Biol Psychiatry. 2016 Aug 1;80(3):179-89. (PMID: 26772405)
      Dev Rev. 2008;28(1):62-77. (PMID: 18688292)
      J Psychiatr Res. 2016 Jun;77:42-51. (PMID: 26978184)
      Behav Brain Res. 2005 May 28;160(2):382-8. (PMID: 15863235)
      Transl Psychiatry. 2016 Apr 26;6:e792. (PMID: 27115123)
      Dev Sci. 2017 Jul;20(4):null. (PMID: 27774764)
      Addict Behav. 2015 Jul;46:45-52. (PMID: 25796007)
      J Neurochem. 2017 Oct 6;:null. (PMID: 28986925)
      Lancet. 2009 Feb 7;373(9662):492-501. (PMID: 19168210)
      Neurosci Biobehav Rev. 2013 May;37(4):681-96. (PMID: 23415703)
      J Child Adolesc Subst Abuse. 2011 Jan 1;20(2):135-154. (PMID: 21532924)
      Arch Ital Biol. 2017 Jul 1;155(1-2):54-62. (PMID: 28715598)
      J Neurosci. 2013 Mar 6;33(10 ):4527-35. (PMID: 23467368)
      Curr Treat Options Psychiatry. 2017 Jun;4(2):196-209. (PMID: 29038777)
      Neurotoxicol Teratol. 2010 Jul-Aug;32(4):443-51. (PMID: 20227491)
      Med Sci Sports Exerc. 2016 Jun;48(6):1223-4. (PMID: 27182987)
      J Stud Alcohol Drugs. 2014 Sep;75(5):729-43. (PMID: 25208190)
      Addict Behav. 2003 Mar;28(2):381-6. (PMID: 12573689)
      Int J Public Health. 2015 Sep;60(6):659-68. (PMID: 26104131)
      Psychophysiology. 2016 Sep;53(9):1335-42. (PMID: 27314635)
      Dev Cogn Neurosci. 2016 Feb;17:103-17. (PMID: 26774291)
      Eur Addict Res. 2017;23 (1):37-44. (PMID: 27960169)
      Addict Behav. 2016 Feb;53:155-60. (PMID: 26517712)
      Neuroimage. 2013 Aug 1;76:412-27. (PMID: 23507394)
      Front Physiol. 2017 Feb 14;8:85. (PMID: 28261108)
      Dev Neuropsychol. 2010;35(5):539-54. (PMID: 20721774)
      J Pediatr Psychol. 2004 Jun;29(4):299-308. (PMID: 15148352)
      Hum Brain Mapp. 2014 May;35(5):2470-82. (PMID: 24038570)
      Methods Mol Biol. 2012;829:231-42. (PMID: 22231817)
      Scand J Med Sci Sports. 2014 Feb;24(1):e52-61. (PMID: 23826633)
      Neurosci Biobehav Rev. 2016 Nov;70:106-120. (PMID: 27545755)
      Prev Med. 2011 Jun;52 Suppl 1:S60-4. (PMID: 21281665)
      J Addict Med. 2016 Nov/Dec;10 (6):429-436. (PMID: 27574753)
      Przegl Epidemiol. 2015;69(4):795-800, 919-22. (PMID: 27139363)
      Neurosci Biobehav Rev. 2011 Apr;35(5):1219-36. (PMID: 21185861)
      MMWR Surveill Summ. 2012 Jun 8;61(4):1-162. (PMID: 22673000)
      PLoS One. 2013 Sep 30;8(9):e76644. (PMID: 24098797)
      Psychol Bull. 2015 Jan;141(1):48-84. (PMID: 25365761)
      Clin Exp Pharmacol Physiol. 2007 Apr;34(4):377-84. (PMID: 17324153)
      Behav Brain Res. 2013 Jun 15;247:34-9. (PMID: 23499703)
      Drug Alcohol Depend. 2009 Jan 1;99(1-3):68-78. (PMID: 18768267)
      Addiction. 2014 Jan;109(1):90-9. (PMID: 23961881)
      Prog Brain Res. 1999;121:327-49. (PMID: 10551035)
      Trends Neurosci. 2015 Jun;38(6):345-52. (PMID: 25959611)
      Health Psychol. 2011 Jan;30(1):91-8. (PMID: 21299297)
      Physiol Behav. 2011 Oct 24;104(5):934-41. (PMID: 21722657)
      Cancer Metastasis Rev. 2011 Jun;30(2):225-38. (PMID: 21267766)
      Prev Sci. 2013 Jun;14(3):257-66. (PMID: 23404658)
      JAMA Intern Med. 2016 Jun 1;176(6):816-25. (PMID: 27183032)
      JAMA. 2000 Oct 4;284(13):1689-95. (PMID: 11015800)
      Addiction. 2017 Nov;112(11):1973-1982. (PMID: 28600881)
      Pediatrics. 2015 Nov;136(5):e1169-77. (PMID: 26504126)
      Psychol Sci. 2016 Apr;27(4):549-62. (PMID: 26911914)
      Exerc Sport Sci Rev. 2000 Apr;28(2):85-8. (PMID: 10902091)
      Trends Cogn Sci. 2005 Feb;9(2):60-8. (PMID: 15668098)
      Neurotoxicol Teratol. 2011 Jan-Feb;33(1):69-77. (PMID: 20600846)
      Psychol Addict Behav. 2015 Sep;29(3):787-93. (PMID: 26415064)
      Behav Brain Res. 2010 Dec 20;215(1):77-82. (PMID: 20615434)
      Drug Alcohol Depend. 2017 Aug 1;177:249-257. (PMID: 28623823)
      J Stud Alcohol Drugs. 2015 Nov;76(6):895-908. (PMID: 26562597)
      Bioessays. 2010 Sep;32(9):748-55. (PMID: 20730946)
      Child Adolesc Psychiatr Clin N Am. 2016 Oct;25(4):685-711. (PMID: 27613346)
      J Psychoactive Drugs. 2015 Nov-Dec;47(5):409-16. (PMID: 26595433)
      Dev Cogn Neurosci. 2014 Jul;9:117-25. (PMID: 24632141)
      Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005381. (PMID: 18425918)
      Addiction. 2011 Oct;106(10):1855-65; discussion 1866-7. (PMID: 21561496)
      Eur J Appl Physiol. 2013 Mar;113(3):713-9. (PMID: 22922803)
      Drug Alcohol Depend. 2014 Apr 1;137:68-75. (PMID: 24513182)
      Psychopharmacology (Berl). 2013 Dec;230(4):663-71. (PMID: 23832422)
      Neuropsychol Rev. 2016 Jun;26(2):186-222. (PMID: 27125202)
      Drug Alcohol Depend. 2014 Mar 1;136:51-62. (PMID: 24434016)
      Neurobiol Aging. 2008 Sep;29(9):1380-93. (PMID: 17467122)
      J Behav Ther Exp Psychiatry. 2015 Dec;49(Pt A):13-20. (PMID: 25843611)
      Br J Sports Med. 2016 Jan;50(2):93-9. (PMID: 26729891)
      Nicotine Tob Res. 2017 May 15;:null. (PMID: 28505303)
      Soc Cogn Affect Neurosci. 2015 Oct;10 (10 ):1383-91. (PMID: 25759470)
      J Am Acad Child Adolesc Psychiatry. 2000 Feb;39(2):223-31. (PMID: 10673834)
      Front Behav Neurosci. 2017 Jul 25;11:134. (PMID: 28790900)
      Cereb Cortex. 2008 Nov;18(11):2523-31. (PMID: 18296435)
      J Pers Soc Psychol. 2004 May;86(5):760-72. (PMID: 15161399)
      Psychiatry Res. 2013 Dec 30;214(3):374-81. (PMID: 24139957)
      Magn Reson Imaging. 2017 Nov;43:10-26. (PMID: 28645698)
      Endocrinology. 1994 Nov;135(5):1753-61. (PMID: 7525251)
      Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):349-65. (PMID: 27338960)
      Neuropharmacology. 2014 Jan;76 Pt B:235-49. (PMID: 23688927)
      J Clin Psychiatry. 2017 Sep/Oct;78(8):1075-1082. (PMID: 28199070)
      Contemp Clin Trials. 2014 Nov;39(2):236-45. (PMID: 25139726)
      Biol Psychiatry. 2011 Oct 15;70(8):763-9. (PMID: 21820648)
      J Clin Psychiatry. 2016 Oct;77(10 ):1396-1403. (PMID: 27574836)
      J Subst Abuse Treat. 2015 Jan;48(1):77-84. (PMID: 25200740)
      Cancer Invest. 2004;22(1):51-67. (PMID: 15069763)
      Annu Rev Pharmacol Toxicol. 2012;52:321-36. (PMID: 21961707)
      Proc Natl Acad Sci U S A. 2004 May 25;101(21):8174-9. (PMID: 15148381)
      N Engl J Med. 1981 Aug 20;305(8):466-7. (PMID: 7254293)
      Biol Psychiatry. 2012 Apr 15;71(8):684-92. (PMID: 22129756)
      Curr Neurovasc Res. 2006 Feb;3(1):15-23. (PMID: 16472122)
      Neuropsychopharmacology. 2014 Aug;39(9):2041-8. (PMID: 24633558)
      Clin Liver Dis. 2016 Aug;20(3):563-80. (PMID: 27373617)
      J Consult Clin Psychol. 2000 Feb;68(1):19-30. (PMID: 10710837)
      J Neurosci. 2007 Oct 17;27(42):11442-50. (PMID: 17942739)
      Dev Psychopathol. 2016 Nov;28(4pt1):1209-1216. (PMID: 27739397)
      Drug Alcohol Depend. 2008 Apr 1;94(1-3):207-13. (PMID: 18222051)
      Annu Rev Psychol. 2015 Jan 3;66:295-319. (PMID: 25089362)
      Neurotoxicol Teratol. 2016 Nov - Dec;58:5-14. (PMID: 27567698)
      Eur J Neurosci. 2016 May;43(9):1190-202. (PMID: 26833814)
      PM R. 2012 Nov;4(11):826-32. (PMID: 23174545)
      Psychol Addict Behav. 2008 Sep;22(3):372-9. (PMID: 18778130)
      Neuropsychopharmacology. 2016 May;41(6):1629-36. (PMID: 26503310)
      Neurosci Biobehav Rev. 2010 Apr;34(5):631-48. (PMID: 20026110)
      Br J Sports Med. 2017 Jul;51(14 ):1058-1064. (PMID: 28087569)
      Addiction. 2017 Nov;112(11):1952-1960. (PMID: 28600897)
      Nat Rev Neurosci. 2012 Sep;13(9):636-50. (PMID: 22903221)
      Child Adolesc Psychiatr Clin N Am. 2016 Apr;25(2):297-305. (PMID: 26980131)
      Rev Bras Psiquiatr. 2016 Jul-Sep;38(3):247-54. (PMID: 27611903)
      Front Hum Neurosci. 2010 Feb 12;4:6. (PMID: 20179786)
      Addict Biol. 2013 Nov;18(6):1013-23. (PMID: 22994937)
      Dev Cogn Neurosci. 2017 Oct 10;:null. (PMID: 29051027)
      Addict Behav. 2013 Jan;38(1):1435-41. (PMID: 23006248)
      Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1592-7. (PMID: 24474784)
      Addict Sci Clin Pract. 2011 Jul;6(1):57-70. (PMID: 22003423)
      Neurosci Lett. 2008 Aug 22;441(2):219-23. (PMID: 18602754)
      Recent Results Cancer Res. 2011;186:1-10. (PMID: 21113758)
      J Stud Alcohol Drugs. 2009 Jul;70(4):489-98. (PMID: 19515288)
      Child Neuropsychol. 2007 May;13(3):205-18. (PMID: 17453830)
      J Adolesc. 2015 Dec;45:20-30. (PMID: 26349450)
      Neuroimage. 2015 Nov 15;122:427-39. (PMID: 26254587)
      Brain Cogn. 2013 Dec;83(3):315-23. (PMID: 24128659)
      J Exerc Rehabil. 2016 Oct 31;12 (5):380-385. (PMID: 27807514)
      Arch Intern Med. 1999 Oct 25;159(19):2349-56. (PMID: 10547175)
      Psychopharmacology (Berl). 2017 Apr;234(8):1293-1305. (PMID: 28210781)
      Int J Drug Policy. 2012 Mar;23(2):120-7. (PMID: 21741815)
      J Adolesc Health. 2017 Jun;60(6):747-750. (PMID: 28258807)
      Exerc Sport Sci Rev. 2011 Oct;39(4):177-86. (PMID: 21799425)
      Front Neurosci. 2014 Nov 10;8:361. (PMID: 25426017)
      Psychopharmacology (Berl). 2012 Jul;222(1):1-15. (PMID: 22585034)
      Drug Alcohol Depend. 2012 Nov 1;126(1-2):65-70. (PMID: 22609061)
      Neuropsychobiology. 2013;68(1):1-14. (PMID: 23774826)
      Curr Top Behav Neurosci. 2012;11:1-24. (PMID: 22016109)
      Neurotoxicol Teratol. 2011 Jan-Feb;33(1):110-9. (PMID: 20609384)
      Exp Neurol. 2010 Nov;226(1):58-67. (PMID: 20696163)
      Proc Natl Acad Sci U S A. 1990 Jul;87(14):5568-72. (PMID: 1695380)
      Horm Metab Res. 2010 Dec;42(13):982-6. (PMID: 21053157)
      Addiction. 1997 Mar;92(3):279-96. (PMID: 9219390)
      Cochrane Database Syst Rev. 2014 Aug 29;(8):CD002295. (PMID: 25170798)
      Br J Health Psychol. 2013 May;18(2):395-406. (PMID: 23013288)
      JAMA Pediatr. 2013 Apr;167(4):348-54. (PMID: 23400239)
      Brain Res. 2010 Oct 28;1358:172-83. (PMID: 20735996)
      Psychiatriki. 2017 Jul-Sep;28(3):234-241. (PMID: 29072187)
      Prev Med. 2017 Feb;95S:S4-S9. (PMID: 27565054)
      Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1:E181-9. (PMID: 23240741)
      J Forensic Sci. 2010 Sep;55(5):1209-17. (PMID: 20487147)
      Neurosci Biobehav Rev. 2013 Sep;37(8):1622-44. (PMID: 23806439)
      PLoS One. 2016 Jan 19;11(1):e0146966. (PMID: 26784516)
      Trends Cogn Sci. 2015 Oct;19(10):558-66. (PMID: 26419496)
      J Stud Alcohol Drugs. 2012 May;73(3):379-90. (PMID: 22456243)
      Int J Cancer. 2009 May 15;124(10):2406-15. (PMID: 19142968)
      Int J Behav Med. 2008;15(2):157-63. (PMID: 18569134)
      Psychopharmacology (Berl). 2006 Oct;188(2):228-35. (PMID: 16915385)
      PLoS One. 2013;8(2):e56438. (PMID: 23418568)
      Eur J Appl Physiol Occup Physiol. 1993;66(3):269-74. (PMID: 8386618)
      Eur J Neurosci. 2003 Nov;18(10):2803-12. (PMID: 14656329)
      J Clin Psychiatry. 2005 Jun;66(6):677-85. (PMID: 15960559)
      Curr Pharm Des. 2016;22(42):6353-6365. (PMID: 27514709)
      Drug Alcohol Depend. 2013 Feb 1;128(1-2):83-9. (PMID: 22938829)
      Nature. 2006 Aug 31;442(7106):1042-5. (PMID: 16929307)
      Clin Psychol Rev. 2001 Feb;21(1):33-61. (PMID: 11148895)
      Soc Cogn Affect Neurosci. 2015 Jan;10(1):106-13. (PMID: 24526186)
      J Stud Alcohol Drugs. 2015 Sep;76(5):738-48. (PMID: 26402354)
      Brain Sci. 2013 Mar 22;3(1):396-414. (PMID: 23914300)
      Addiction. 2009 Nov;104(11):1910-7. (PMID: 19832788)
      Mol Psychiatry. 2010 Dec;15(12):1128-39. (PMID: 21102431)
      Neurorehabil Neural Repair. 2009 Jul-Aug;23(6):600-8. (PMID: 19131578)
      Am J Drug Alcohol Abuse. 2004;30(1):39-59. (PMID: 15083553)
      Addict Biol. 2013 May;18(3):570-80. (PMID: 22264344)
      Nat Rev Neurosci. 2009 Apr;10(4):303-12. (PMID: 19277053)
      Dev Cogn Neurosci. 2016 Feb;17:83-93. (PMID: 26771250)
      Am J Psychiatry. 2012 Aug;169(8):805-12. (PMID: 22706327)
      Neurotoxicol Teratol. 2011 Jan-Feb;33(1):100-9. (PMID: 20600847)
      Trends Neurosci. 2007 Sep;30(9):464-72. (PMID: 17765329)
      Drug Alcohol Rev. 2011 Jul;30(4):381-7. (PMID: 21355905)
      Am J Psychiatry. 2001 Dec;158(12 ):2015-21. (PMID: 11729018)
      Addiction. 2013 Jan;108(1):26-37. (PMID: 22861822)
      Cochrane Database Syst Rev. 2015 Apr 22;(4):CD005381. (PMID: 25900537)
      Dev Cogn Neurosci. 2016 Feb;17 :57-67. (PMID: 26708774)
      Oncotarget. 2016 Dec 13;7(50):83134-83147. (PMID: 27863414)
      Ment Health Phys Act. 2011 Dec;4(2):79-87. (PMID: 22125581)
      Brain Cogn. 2014 Aug;89:104-11. (PMID: 24556507)
      Drug Alcohol Depend. 2008 May 1;95(1-2):1-13. (PMID: 18242006)
      J Perinatol. 2012 Nov;32(11):819-28. (PMID: 22791278)
      J Adolesc Health. 2013 Jan;52(1):35-41. (PMID: 23260832)
      Herz. 2016 Sep;41(6):484-93. (PMID: 27582365)
      Curr Opin Investig Drugs. 2010 Jan;11(1):63-71. (PMID: 20047160)
      J Psychiatr Res. 2015 Jan;60:56-64. (PMID: 25455510)
      Parkinsonism Relat Disord. 2016 Mar;24:56-62. (PMID: 26857399)
      Science. 2010 Jul 30;329(5991):532. (PMID: 20671181)
      PLoS One. 2011 Mar 08;6(3):e17465. (PMID: 21408154)
    • Grant Information:
      R01 CA175100 United States CA NCI NIH HHS
    • Contributed Indexing:
      Keywords: adolescence; exercise; neurobiology; substance use; “assisted” exercise
    • Publication Date:
      Date Created: 20171219 Date Completed: 20180810 Latest Revision: 20181201
    • Publication Date:
      20200827
    • Accession Number:
      PMC5751741
    • Accession Number:
      10.1002/bdr2.1182
    • Accession Number:
      29251846
  • Citations
    • ABNT:
      NOCK, N. L.; MINNES, S.; ALBERTS, J. L. Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders. Birth defects research, [s. l.], v. 109, n. 20, p. 1711–1729, 2017. DOI 10.1002/bdr2.1182. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdc&AN=29251846. Acesso em: 26 set. 2020.
    • AMA:
      Nock NL, Minnes S, Alberts JL. Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders. Birth defects research. 2017;109(20):1711-1729. doi:10.1002/bdr2.1182
    • APA:
      Nock, N. L., Minnes, S., & Alberts, J. L. (2017). Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders. Birth Defects Research, 109(20), 1711–1729. https://doi.org/10.1002/bdr2.1182
    • Chicago/Turabian: Author-Date:
      Nock, Nora L, Sonia Minnes, and Jay L Alberts. 2017. “Neurobiology of Substance Use in Adolescents and Potential Therapeutic Effects of Exercise for Prevention and Treatment of Substance Use Disorders.” Birth Defects Research 109 (20): 1711–29. doi:10.1002/bdr2.1182.
    • Harvard:
      Nock, N. L., Minnes, S. and Alberts, J. L. (2017) ‘Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders’, Birth defects research, 109(20), pp. 1711–1729. doi: 10.1002/bdr2.1182.
    • Harvard: Australian:
      Nock, NL, Minnes, S & Alberts, JL 2017, ‘Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders’, Birth defects research, vol. 109, no. 20, pp. 1711–1729, viewed 26 September 2020, .
    • MLA:
      Nock, Nora L., et al. “Neurobiology of Substance Use in Adolescents and Potential Therapeutic Effects of Exercise for Prevention and Treatment of Substance Use Disorders.” Birth Defects Research, vol. 109, no. 20, Dec. 2017, pp. 1711–1729. EBSCOhost, doi:10.1002/bdr2.1182.
    • Chicago/Turabian: Humanities:
      Nock, Nora L, Sonia Minnes, and Jay L Alberts. “Neurobiology of Substance Use in Adolescents and Potential Therapeutic Effects of Exercise for Prevention and Treatment of Substance Use Disorders.” Birth Defects Research 109, no. 20 (December 1, 2017): 1711–29. doi:10.1002/bdr2.1182.
    • Vancouver/ICMJE:
      Nock NL, Minnes S, Alberts JL. Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders. Birth defects research [Internet]. 2017 Dec 1 [cited 2020 Sep 26];109(20):1711–29. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdc&AN=29251846